Business ❯Pharmaceutical Industry

Vaccine Market

RSV Vaccines Profitability Competitive Landscape Regulatory Approvals Flu Vaccine Sales Market Withdrawal

FDA Advisers Recommend JN.1-Based COVID Vaccine for Fall

New formula aims to improve protection against evolving variants as manufacturers prepare for autumn rollout.

FDA Approves Moderna's mRNA RSV Vaccine for Older Adults

Pfizer's RSV Vaccine Shows Sustained Efficacy in Older Adults

FDA Approves Pfizer's RSV Vaccine for Seniors After Success in Late-Stage Trials